L3VLUP
ProSign in

KRYS · ARGX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

KRYSARGX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • KRYS
  • ARGX
0102030202120222023202420252026
Holders and value by quarter
QuarterKRYSARGX
Q3 20204 holders, $52m8 holders, $3.6bn
Q4 20203 holders, $66m7 holders, $4.1bn
Q1 20213 holders, $67m8 holders, $4.1bn
Q2 20212 holders, $28m9 holders, $4.6bn
Q3 20212 holders, $31m8 holders, $4.5bn
Q4 20212 holders, $135m9 holders, $5.3bn
Q1 20221 holders, $114m8 holders, $5.3bn
Q2 20222 holders, $107m13 holders, $6.5bn
Q3 20223 holders, $97m14 holders, $5.3bn
Q4 20223 holders, $59m13 holders, $5.5bn
Q1 20233 holders, $59m13 holders, $5.9bn
Q2 20233 holders, $82m18 holders, $6.6bn
Q3 20235 holders, $143m21 holders, $8.7bn
Q4 20235 holders, $109m17 holders, $6.3bn
Q1 20248 holders, $853m13 holders, $6.8bn
Q2 20246 holders, $1.0bn14 holders, $7.9bn
Q3 20245 holders, $976m13 holders, $10.7bn
Q4 20245 holders, $850m14 holders, $12.3bn
Q1 20255 holders, $993m17 holders, $11.8bn
Q2 20254 holders, $746m18 holders, $10.8bn
Q3 20255 holders, $938m16 holders, $13.8bn
Q4 20257 holders, $1.4bn16 holders, $14.8bn
Q1 20266 holders, $1.5bn11 holders, $12.3bn
Q2 20266 holders, $2.4bn14 holders, $15.0bn
KRYS

Krystal Biotech Inc

Holders
8
Reported value
$853m
Buyers
5
Sellers
2

Breadth +3 among 93 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
ARGX

Argenx Se

Holders
13
Reported value
$6.8bn
Buyers
6
Sellers
8

Breadth -2 among 93 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q1 2024

Among the 19 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only KRYS (6)

Brevan Howard Capital Management LP, Caxton Associates LLP, Farallon Capital Management LLC, Man Group PLC, Verition Fund Management LLC, Woodline Partners LP

Only ARGX (11)

Artisan Partners LP, ExodusPoint Capital Management LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Janus Henderson Group Ltd, Marshall Wace LLP, MFS Investment Management, Moore Capital Management LP, Point72 Asset Management LP, Soros Fund Management LLC, T. Rowe Price Associates Inc

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →